Coronary/Structural Heart Boston Scientific says Lotus out until Next Year Share by Ken Dropiewski on February 2, 2018 More in Coronary/Structural Heart: Catalyst MedTech Helps Imaging Providers See What’s Next in Nuclear Cardiology at ASNC 2026 September 14, 2026 New Cardiovascular Device Approved in Japan: Elixir Medical Announces Regulatory Approval of DynamX® Coronary Bioadaptor System September 14, 2026 Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy September 14, 2026 Share this story Facebook Twitter LinkedIn Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of reports of early release of a pin connecting the transcatheter valve to the delivery system…. Read Full Article at Medscape here